Affiliate Rewards Eligible Companies
Total Page：16
File Type：pdf, Size：1020Kb
Load more
Recommended publications
-
From the Academy
FROM THE ACADEMY Joint American Academy of DermatologyeNational Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with phototherapy Craig A. Elmets, MD (Co-Chair),a HenryW.Lim,MD,b Benjamin Stoff, MD, MA,c Cody Connor, MD,a Kelly M. Cordoro, MD,d Mark Lebwohl, MD,e AprilW.Armstrong,MD,MPH,f Dawn M. R. Davis, MD,g Boni E. Elewski, MD,a Joel M. Gelfand, MD, MSCE,h Kenneth B. Gordon, MD,i AliceB.Gottlieb,MD,PhD,j Daniel H. Kaplan, MD, PhD,k Arthur Kavanaugh, MD,l Matthew Kiselica, BA/BS,m Dario Kivelevitch, MD,n Neil J. Korman, MD, PhD,o Daniela Kroshinsky, MD, MPH,p Craig L. Leonardi, MD,q Jason Lichten, MD,m NehalN.Mehta,MD,MSCE,r Amy S. Paller, MD,s Sylvia L. Parra, MD,t Arun L. Pathy, MD,u Elizabeth A. Farley Prater, MD,v Reena N. Rupani, MD,e Michael Siegel, PhD,m BruceE.Strober,MD,PhD,w,x Emily B. Wong, MD,y Jashin J. Wu, MD,z Vidhya Hariharan, PhD,aa and Alan Menter, MD (Co-Chair)n Birmingham, Alabama; Detroit, Michigan; Atlanta, Georgia; San Francisco, Los Angeles, San Diego, and Irvine, California; New York, New York; Rochester, Minnesota; Philadelphia and Pittsburgh, Pennsylva- nia; Milwaukee, Wisconsin; Portland, Oregon; Dallas and San Antonio, Texas; Cleveland, Ohio; Boston, Massachusetts; St. Louis, Missouri; Bethesda, Maryland; Chicago and Rosemont, Illinois; Sumter, South Carolina; Centennial, Colorado; Oklahoma City, Oklahoma; Farmington, Connecticut; and Waterloo, Ontario, Canada Psoriasis is a chronic inflammatory disease involving multiple organ systems and affecting approximately 3.2% of the world’s population. -
Annual Report on Annual Reports 2016
ANNUAL REPORT ON ANNUAL REPORTS 2016 TOP 400 ANNUAL REPORTS WHO RANKS WHERE? 100 ANNUALS IN BRIEF BEST REPORTING PRACTICES Company Value > Report Value Annual Report on Annual Reports 2016 Contents Report rating scale 3 Top 400 annual reports 4 Who ranks where? 25 From ABB to ZTE 100 annuals in brief 58 From Abbott to Yamaha How important is the annual report today? 92 Views from Cecilia Ketels, Kellie Friery, Renee Carter, David Robinson, Kaevan Gazdar, Elena Moskvina, Thomas Rosenmayr, Rob Stangroom, Andrey Kozhevnikov, Ana Santamarina, Katie Holcomb, Ananda Jagoda Best practices on key report attibutes 100 Strategy, message, investor information, risks, style, online… How we make it 121 How is your report doing? The report scan 127 The report rating panel 128 Robert Berick, Susan Blesener, Renee Carter, Vero Escarmelle, Helena Fournial, Kaevan Gazdar, Mike Guillaume, Pradip Seth, Eva Wolosiuk Making reports pay off 133 e.com – ReportWatch 135 2 Report rating scale A+ ééééé First-rate A éééé(é) Excellent A- éééé Very good B+ ééé(é) Sound B ééé Average B- éé(é) Uneven C+ éé Common C é(é) Substandard C- é Poor D (é) Uncompetitive 3 Top 400 annual reports AkzoNobel (No. 1) Electrolux (No. 2 ) SCA (No. 3) Volvo (No. 4) 4 Report rank Company Country Report rating Compare 1 AKZONOBEL Netherlands A+ DUPONT 2 ELECTROLUX Sweden A+ WHIRLPOOL 3 SCA Sweden A+ KIMBERLY-CLARK 4 VOLVO Sweden A+ DAIMLER 5 POTASHCORP Canada A+ AGRIUM 6 ATLAS COPCO Sweden A SANDVIK 7 STORA ENSO Finland A UPM 8 BOLIDEN Sweden A GLENCORE 9 WIENERBERGER Austria A BORAL 10 -
Case 2:16-Cv-03302-SFC-RSW ECF No. 15 Filed 03/03/17 Pageid
Case 2:16-cv-03302-SFC-RSW ECF No. 15 filed 03/03/17 PageID.<pageID> Page 1 of 12 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF MICHIGAN SOUTHERN DIVISION _________________________________ IN RE: AUTOMOTIVE PARTS ANTITRUST LITIGATION MASTER FILE NO. 12-md-02311 _________________________________ In Re: Shock Absorbers HON. MARIANNE O. BATTANI _________________________________ THIS DOCUMENT RELATES TO: Dealership Actions 16-03302 End-Payor Actions 15-03303 _________________________________/ OPINION AND ORDER GRANTING IN PART AND DENYING IN PART MOTION TO DISMISS THE END-PAYORS’ AND THE AUTO DEALERS’ CLASS ACTION COMPLAINTS Before the Court is Defendants KYB Corporation, f/k/a/ Kayaba Industry Co., Ltd., (“KYB Industry) and KYB Americas Corporation (“KYB Corporation”) (collectively “KYB Defendants”) Collective Motion to Dismiss the End-Payor Plaintiffs’ and Auto Dealer Plaintiffs’ Class Action Complaints (Doc. No. 3 in 16-3302; Doc. No. 23 in 15- 3303). In their motion, KYB Defendants challenge the sufficiency of the allegations of the conspiracy pursuant to Fed. R. Civ. P. 12(b)(6). The Court has reviewed all of the filings, The Court has reviewed all of the filings, and for the reasons that follow, the motion is GRANTED in part and DENIED in part. Case 2:16-cv-03302-SFC-RSW ECF No. 15 filed 03/03/17 PageID.<pageID> Page 2 of 12 I. INTRODUCTION AND FACTUAL ALLEGATIONS After the United States Judicial Panel on Multidistrict Litigation (“Judicial Panel” or “Panel”) transferred actions sharing “factual questions arising out of an alleged conspiracy to inflate, fix, raise, maintain, or artificially stabilize prices of automotive wire harness systems” to the Eastern District of Michigan, (12-md-02311, Doc. -
Auto Parts Canadian Settlements
AUTO PARTS CANADIAN SETTLEMENTS Settlement Amount Action Settled Defendant(s) (CDN) Approved Hearing Date (unless otherwise indicated) Air Conditioning DENSO Corporation et al $4,943,000 Feb 28/20 n/a Systems Panasonic Corporation et al $126,000 n/a May 13/21 Marelli Corporation (f/k/a $878,935.99 n/a May 13/21 Calsonic Kansei Corporation) et al Air Flow Meters Hitachi, Ltd., et al $725,000 May 1/17 n/a DENSO Corporation et al $150,000 Feb 28/20 n/a Alternators Hitachi, Ltd., et al $950,000 May 1/17 n/a Mitsubishi Electric $2,200,000 Sept 21/18 n/a Corporation et al DENSO Corporation et al $5,120,000 Feb 28/20 n/a ATF Warmers and Oil T.RAD Co., Ltd. et al $113,476.33 Jun 19/18 n/a Coolers DENSO Corporation et al $302,000 Feb 28/20 n/a Marelli Corporation (f/k/a $64,867.52 n/a May 13/21 Calsonic Kansei Corporation) et al Autolights Mitsuba Corporation et al $150,000 May 28/19 n/a Koito Manufacturing Co., $3,666,000 Aug 27/20 n/a Ltd. et al. Automotive Brake Hitachi Metals, Ltd. et al $175,000 Feb 28/20 n/a Hoses Toyoda Gosei Co., Ltd. $97,419.03 Aug 27/20 n/a Automotive Constant- Toyo Tire & Rubber Co., $258,969.19 Aug 27/20 n/a Velocity-Joint Boot Ltd. et al Products Toyoda Gosei Co., Ltd. $105,846.66 Aug 27/20 n/a Automotive Exhaust DENSO Corporation et al $150,000 Feb 28/20 n/a Systems NGK Spark Plugs (U.S.A.), $66,510 Feb 28/20 n/a Inc., et al Eberspächer Gruppe GmbH $190,000 Aug 27/20 n/a & Co. -
Mizuho BK Custody and Proxy Board Lot Size List OCT 27, 2020 21LADY
Mizuho BK Custody and Proxy Board Lot Size List OCT 27, 2020 Board Lot Stock Name (in Alphabetical Order) ＩＳＩＮ Code ＱＵＩＣＫ Code Size 21LADY CO.,LTD. 100 JP3560550000 3346 3-D MATRIX,LTD. 100 JP3410730000 7777 4CS HOLDINGS CO.,LTD. 100 JP3163300001 3726 A DOT CO.,LTD 100 JP3160590000 7063 A-ONE SEIMITSU INC. 100 JP3160660001 6156 A.D.WORKS GROUP CO.,LTD. 100 JP3160560003 2982 A&A MATERIAL CORPORATION 100 JP3119800005 5391 A&D COMPANY,LIMITED 100 JP3160130005 7745 A&T CORPORATION 100 JP3160680009 6722 ABALANCE CORPORATION 100 JP3969530009 3856 ABC-MART,INC. 100 JP3152740001 2670 ABHOTEL CO.,LTD. 100 JP3160610006 6565 ABIST CO.,LTD. 100 JP3122480001 6087 ACCESS CO.,LTD. 100 JP3108060009 4813 ACCESS GROUP HOLDINGS CO.,LTD. 100 JP3108190004 7042 ACCRETE INC. 100 JP3108180005 4395 ACHILLES CORPORATION 100 JP3108000005 5142 ACMOS INC. 100 JP3108100003 6888 ACOM CO.,LTD. 100 JP3108600002 8572 ACRODEA,INC. 100 JP3108120001 3823 ACTCALL INC. 100 JP3108140009 6064 ACTIVIA PROPERTIES INC. 1 JP3047490002 3279 AD-SOL NISSIN CORPORATION 100 JP3122030004 3837 ADASTRIA CO.,LTD. 100 JP3856000009 2685 ADEKA CORPORATION 100 JP3114800000 4401 ADISH CO.,LTD. 100 JP3121500007 7093 ADJUVANT COSME JAPAN CO.,LTD. 100 JP3119620007 4929 ADTEC PLASMA TECHNOLOGY CO.,LTD. 100 JP3122010006 6668 ADVAN CO.,LTD. 100 JP3121950004 7463 ADVANCE CREATE CO.,LTD. 100 JP3122100005 8798 ADVANCE RESIDENCE INVESTMENT CORPORATION 1 JP3047160001 3269 ADVANCED MEDIA,INC. 100 JP3122150000 3773 ADVANEX INC. 100 JP3213400009 5998 ADVANTAGE RISK MANAGEMENT CO.,LTD. 100 JP3122410008 8769 ADVANTEST CORPORATION 100 JP3122400009 6857 ADVENTURE,INC. 100 JP3122380003 6030 ADWAYS INC. 100 JP3121970002 2489 AEON CO.,LTD. 100 JP3388200002 8267 AEON DELIGHT CO.,LTD. -
JOB POSTING Duties and Other Work Elements
This document is used to provide a basic description of essential JOB POSTING duties and other work elements. Job Title: Application Systems Analyst KYB Americas Corporation, a subsidiary of one of the world's largest manufacturers of shocks, struts and hydraulic components, and a global leader in ride control technology, has announced the expansion of the KYB Manufacturing facility in Franklin, Indiana. KYB Americas Corporation is growing and we're seeking an Application Systems Analyst to join our team! If you are interested in a growing, fast-paced, collaborative company with lots of opportunity and a company who understands the importance of work / life balance, KYB Americas Corporation is the place for you! Purpose of Position/Summary: The Application Systems Analyst will be a part of the Information Technology Department. This position will be responsible for maintenance, testing, and supporting QAD and all related systems and users. Essential Duties/Responsibilities: Create programming changes as defined by the process owners to meet business needs; Preserve a consistent and usable interface over the database and business logic provided in a multi-tier environment; Provide program change management, unit testing or other testing and help in developing plans to complete projects assigned; Perform tasks as required to help resolve calls to the Help Desk using strong analytical and problem solving skills, including but not limited to: performing the programming necessary to correct the problems; Integrate other 3rd party software into the common architect / framework as seamlessly as possible; Participate in team or corporate projects that are designed to improve the quality of products and services; May be required to spend time on research and development of new software packages, latest versions of supported software and new directions in hardware technology; Other duties may be assigned by immediate Supervisor or Manager on an as needed basis. -
Sales of $20.7 Billion Reflecting Growth of 1.9%, Operational Growth of 3.2
RESULTS HAVE BEEN UPDATED IN ACCORDANCE WITH THE FORM 8-K FILED ON OCTOBER 23, 2019 JOHNSON & JOHNSON REPORTS 2019 THIRD-QUARTER RESULTS: • Sales of $20.7 billion reflecting growth of 1.9%, operational growth of 3.2%* and adjusted operational growth of 5.2%* • EPS of $0.66 decreased (54.2)%; adjusted EPS of $2.12 increased 3.4%* • Company increasing Full Year Sales and EPS guidance due to strong performance New Brunswick, N.J. (October 23, 2019) – Johnson & Johnson (NYSE: JNJ) today announced results for third-quarter 2019. “Our third-quarter results represent strong performance, driven by competitive underlying growth in Pharmaceuticals and Medical Devices, as well as continued optimization in our Consumer business,” said Alex Gorsky, Chairman and Chief Executive Officer. “As we look ahead, we remain confident in the strength of our broad-based business model, which is fueled by our disciplined portfolio management, focus on transformational innovation and dedicated employees around the world who position us for success today and well into the future.” OVERALL FINANCIAL RESULTS: THIRD QUARTER ($ in Millions, except EPS) 2019 2018 % Change Reported Sales $ 20,729 $ 20,348 1.9% Net Earnings 1,753 3,934 (55.4) EPS (diluted) $ 0.66 $ 1.44 (54.2) Non-GAAP* THIRD QUARTER ($ in Millions, except EPS) 2019 2018 % Change Operational Sales1,2 3.2% Adjusted Operational Sales1,3 5.2 Adjusted Net Earnings1,4 5,672 5,590 1.5 Adjusted EPS (diluted)1,4 $ 2.12 $ 2.05 3.4 1 Non-GAAP financial measure; refer to reconciliations of non-GAAP financial measures -
Annual Report 2018 Year Ended March 31, 2018 Government Policies; and Political Instability in Principal Markets
Contents 1 What is KYB? 4 Ten-Years Summary 6 To Our Shareholders and Investors 10 Corporate Governance 13 Management 14 Risk Information 16 Financial Review 18 Financial Statements 24 KYB in Globe 26 Corporate Information 27 Shareholder Information Forward-Looking Statements This annual report contains forward-looking statements, including KYB’s plans and strategies, as well as statements that report historical results. Forward-looking statements involve such known and unknown risks KYB Corporation and uncertainties as economic conditions; currency exchange rates; laws, regulations, and Annual Report 2018 Year Ended March 31, 2018 government policies; and political instability in principal markets. KYB Corporation Annual Report 2018 What is KYB? KYB in Everyday Living At a Glance Aircraft Components As a pioneer in hydraulic technology, KYB is active in a wide range of fields, including automobiles, motorcycles, construction machinery, railroad cars, aircraft, special-purpose vehicles, seismic isolation systems, vibration control dampers, and marine equipment. By developing advanced products that combine hydraulics with vibration control, power control, and Agricultural Machinery systemization technology, KYB has earned the trust of customers around the world. We aim to continue Railroad Equipment earning customer and stakeholder support with our relentless drive to create the technologies and products of tomorrow. Building Equipment Vibration Special-purpose Vehicles Control Technology Construction Machinery Automotive Components Automobiles -
Method to Increase the Accuracy of Large Crankshaft Geometry Measurements Using Counterweights to Minimize Elastic Deformations
applied sciences Article Method to Increase the Accuracy of Large Crankshaft Geometry Measurements Using Counterweights to Minimize Elastic Deformations Leszek Chybowski * , Krzysztof Nozdrzykowski, Zenon Grz ˛adziel , Andrzej Jakubowski and Wojciech Przetakiewicz Faculty of Marine Engineering, Maritime University of Szczecin, ul. Willowa 2-4, 71-650 Szczecin, Poland; [email protected] (K.N.); [email protected] (Z.G.); [email protected] (A.J.); [email protected] (W.P.) * Correspondence: [email protected]; Tel.: +48-914-809-412 Received: 26 May 2020; Accepted: 7 July 2020; Published: 9 July 2020 Abstract: Large crankshafts are highly susceptible to flexural deformation that causes them to undergo elastic deformation as they revolve, resulting in incorrect geometric measurements. Additional structural elements (counterweights) are used to stabilize the forces at the supports that fix the shaft during measurements. This article describes the use of temporary counterweights during measurements and presents the specifications of the measurement system and method. The effect of the proposed solution on the elastic deflection of a shaft was simulated with FEA, which showed that the solution provides constant reaction forces and ensures nearly zero deflection at the supported main journals of a shaft during its rotation (during its geometry measurement). The article also presents an example of a design solution for a single counterweight. Keywords: large crankshafts; minimization of elastic deformation; increasing measurement precision; device stabilizing reaction forces; measurement procedures 1. Introduction The geometries of small machine components are easily measured because they are very common in mechanical engineering, and the relevant measurement instruments are available [1,2]. -
Human Resources Department 1 Job Title: Business Planner Department: Planning KYB Americas Corporation, a Subsidiary of One Of
Human Resources Department Job Title: Business Planner Department: Planning KYB Americas Corporation, a subsidiary of one of the world's largest manufacturers of shocks, struts and hydraulic components, and a global leader in ride control technology, has announced the expansion of the KYB Manufacturing facility in Franklin, Indiana. KYB Americas Corporation is growing and we're seeking a Business Planner to join our team! If you are interested in a growing, fast-paced, collaborative company with lots of opportunity and a company who understands the importance of work / life balance, KYB Americas Corporation is the place for you! Responsibilities: Support upper management with creation of Regional Policy, Corporate Policy and business plans. Responsible for analyzing monthly financial results and identifying any gaps compared to plan and forecast. Create financial forecasts based on historical trend, current business needs and management goals. Recommend actions based on financial analysis to improve and meet company financial targets. Coordinate meetings to review progress/performance of each department. Analyze market and economic trends on a global basis and gather information from other KYB subsidiaries and related companies. Ability to travel both domestic and international. Other duties assigned by immediate Supervisor or Manager on an as needed basis. Qualifications: Bachelor of Science degree in one of the following disciplines: Accounting, Finance, Economics, Management or Engineering is required with 0 to 5 years of business industry experience. High level of proficiency in Microsoft Excel, Microsoft PowerPoint, and Microsoft Access (Excel – advanced spreadsheet ability; Access – analysis and database development). Excellent analytical, quantification, evaluation and problem solving skills are necessary for this position. -
Development of the CENTURION Jet Fuel Aircraft Engines at TAE
Development of the CENTURION Jet Fuel Aircraft Engines at TAE 25th April 2003, Friedrichshafen, Germany Thielert Group The Thielert group has been developing and manufacturing components for high performance engines, as well as special parts with complex geometries made from high-quality super alloys for various applications. Our engineers are developing solutions to optimize internal combustion engines for the racing-, prototyping- and the aircraft industry. We specialize in manufacturing, design, analysis, R&D, prototyping and testing. We work with our customers from the initial concept through to production. www.Thielert.com Company Structure Thielert AG Thielert Motoren GmbH Thielert Aircraft Engines GmbH Hamburg Lichtenstein High-Performance Engines, Manufacturing of components and Components and Engine Management parts with complex geometries Systems, Manufacturing of Prototype- and Race Cars Design Organisation according to JAR-21 Subpart JA Production Organisation according to JAR-21 Subpart G Aircraft Engines according to JAR-E Engine installation acc. to JAR-23 Turnover 18,0 Mio. EUR 16,0 16,2 14,0 12,0 13,0 10,0 9,6 8,0 6,0 6,9 5,3 4,0 3,3 2,0 0,0 1997 1998 1999 2000 2001 2002 Employees 120 112 100 99 80 71 60 40 41 35 20 27 0 199719981999200020012002 Founded 1989 as a One-Man-Company. Competency has increased steadily due to very low employee turnover. Company Profile Aviation: Production of jet fuel aircraft engines Production of precision components for the aviation industry (including engine components and structural parts) Development and production of aircraft electronics assemblies (Digital engine control units) Automotive (Prototypes, pilot lots, motor racing): Production of engine components (including high-performance cam-and crank shafts) Development and production of electronic assemblies (Engine control units, control software) Engineering Services (including test facilities, optimisation of engine concepts) Current List of Customers Automotive Bugatti Engineering GmbH, Wolfsburg DaimlerChrysler AG, Untertürkheim Dr. -
FDA Listing of Authorized Generics As of July 1, 2021
FDA Listing of Authorized Generics as of July 1, 2021 Note: This list of authorized generic drugs (AGs) was created from a manual review of FDA’s database of annual reports submitted to the FDA since January 1, 1999 by sponsors of new drug applications (NDAs). Because the annual reports seldom indicate the date an AG initially entered the market, the column headed “Date Authorized Generic Entered Market” reflects the period covered by the annual report in which the AG was first reported. Subsequent marketing dates by the same firm or other firms are not included in this listing. As noted, in many cases FDA does not have information on whether the AG is still marketed and, if not still marketed, the date marketing ceased. Although attempts have been made to ensure that this list is as accurate as possible, given the volume of d ata reviewed and the possibility of database limitations or errors, users of this list are cautioned to independently verify the information on the list. We welcome comments on and suggested changes (e.g., additions and deletions) to the list, but the list may include only information that is included in an annual report. Please send suggested changes to the list, along with any supporting documentation to: [email protected] A B C D E F G H I J K L M N O P Q R S T U V X Y Z NDA Applicant Date Authorized Generic Proprietary Name Dosage Form Strength Name Entered the Market 1 ACANYA Gel 1.2% / 2.5% Bausch Health 07/2018 Americas, Inc.